IPG Photonics (NASDAQ:IPGP) Posts Q2 Revenue of $279M, Adjusted EPS Beats by 49%
Adjusted EPS of $0.58 crushed the $0.39 estimate as gross margin hit 40.4%, but GAAP net income fell 21% , here is what drove the divergence.
IPG Photonics Corporation (NASDAQ: IPGP) is a technology company, listed on the NASDAQ. Alpha Stocks Insight has published 2 articles on IPGP since Tuesday, August 4, 2026, most recently "IPG Photonics (NASDAQ:IPGP) Signs €300M Deal to Acquire Lumibird Medical" on Tuesday, September 8, 2026. Coverage to date spans Technology and Earnings Report, tracking IPGP's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
IPG Photonics just signed a €300M deal for Lumibird Medical, with up to €50M more tied to 2026-2027 performance, funded entirely from its $871M cash pile.
Adjusted EPS of $0.58 crushed the $0.39 estimate as gross margin hit 40.4%, but GAAP net income fell 21% , here is what drove the divergence.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.